NCT04160078

Brief Summary

The study investigates the effects of a mindfulness intervention on sleep and subsequent cardio-metabolic risk in an adult Atlanta population aged 18 and older.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable diabetes

Timeline
Completed

Started Dec 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 8, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 12, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

December 18, 2019

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 17, 2021

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 29, 2021

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

September 28, 2022

Completed
Last Updated

September 28, 2022

Status Verified

September 1, 2022

Enrollment Period

1.7 years

First QC Date

November 8, 2019

Results QC Date

August 18, 2022

Last Update Submit

September 13, 2022

Conditions

Keywords

DiabetesMindfulnessPublic healthSleep

Outcome Measures

Primary Outcomes (6)

  • Pittsburgh Sleep Quality Index (PSQI) Score

    Global sleep quality was measured via the validated Pittsburgh Sleep Quality Index (PSQI). The PSQI is a self-rated questionnaire which assesses several dimensions of sleep including sleep quality, duration, and disturbances over a 1-month time interval. In scoring the PSQI, seven component scores are derived, each scored 0 (no difficulty) to 3 (severe difficulty). The component scores are summed to produce a global score which ranges from 0 to 21. Poor sleep quality is defined as a global score of 5 or greater.

    Baseline, 4 weeks post-intervention

  • Sleep Duration

    Sleep duration was measured in hours and minutes using a sleep 7-day actigraphy (Philips Respironics Actiwatch Spectrum Plus) on the non-dominant wrist, and confirmed with daily sleep logs. Self-reported sleep duration was also measured.

    Baseline, 4 weeks post-intervention

  • Perceived Stress Scale (PSS)

    The perceived stress scale is a validated tool to help understand how different situations affect feelings and perceived stress. The PSS has 10 items which are responded to on a 5-point scale where 0 = never and 4 = very often. Total scores range from 0 to 40 and higher scores indicate higher perceived stress.

    Baseline, 4 weeks post-intervention

  • Number of Participants With PSS Score Indicating Low Stress

    The perceived stress scale is a validated tool to help understand how different situations affect feelings and perceived stress. The PSS has 10 items which are responded to on a 5-point scale where 0 = never and 4 = very often. Total scores range from 0 to 40 and higher scores indicate higher perceived stress. Participants with scores of 0 to 13 are categorized as having low stress.

    Baseline, 4 weeks post-intervention

  • Number of Participants With PSS Score Indicating Moderate Stress

    The perceived stress scale is a validated tool to help understand how different situations affect feelings and perceived stress. The PSS has 10 items which are responded to on a 5-point scale where 0 = never and 4 = very often. Total scores range from 0 to 40 and higher scores indicate higher perceived stress. Participants with scores of 14 to 26 are categorized as having moderate stress.

    Baseline, 4 weeks post-intervention

  • Number of Participants With PSS Score Indicating High Stress

    The perceived stress scale is a validated tool to help understand how different situations affect feelings and perceived stress. The PSS has 10 items which are responded to on a 5-point scale where 0 = never and 4 = very often. Total scores range from 0 to 40 and higher scores indicate higher perceived stress. Participants with scores of 27 to 40 are categorized as having high stress.

    Baseline, 4 weeks post-intervention

Secondary Outcomes (3)

  • Weight

    Baseline, 4 weeks post-intervention

  • Body Mass Index (BMI)

    Baseline, 4 weeks post-intervention

  • Blood Pressure

    Baseline, 4 weeks post-intervention

Study Arms (1)

Mindfulness Intervention Arm

EXPERIMENTAL

A stress reduction plus sleep education intervention to improve sleep health

Behavioral: Mindfulness-based stress reduction (MBSR) Intervention

Interventions

* 1-hour session on sleep hygiene and 7-week follow up using a mindfulness app, an app that features guided meditation and can be used to assess adherence. * Sleep log diary: self report of sleep records * Wrist Actigraphy, to monitor sleep patterns. Participants will be instructed on wearing the sleep monitor (Spectrum, Philips Respironics, Murrysville, PA) on their non-dominant wrist for the next 7-weeks

Also known as: MBSR Intervention
Mindfulness Intervention Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Resident in the Atlanta, Georgia area
  • Proficient in English
  • Have a smartphone
  • Sleep quality score \>5 on the validated Pittsburgh Sleep Quality Index
  • Prediabetes (defined as fasting glucose between 100-125 mg/dL or HbA1c between 5.7-6.4%)

You may not qualify if:

  • Pregnant women
  • Sleep quality score less than a score 5 on the validated Pittsburgh Sleep Quality Index
  • Refusal to download Mindfulness mobile application
  • Diagnosis of HIV, AIDS, Liver disease (diagnosed, i.e. chronic or alcoholic hepatitis, cirrhosis), Renal/Kidney disease
  • Current Cocaine, heroin, or methamphetamines use and/or has a history of treatment for alcohol or drug abuse
  • Pre-diabetes: defined as a score greater than 3 on the American Diabetes Association 60-Second Type 2 Diabetes Risk Test

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emory University

Atlanta, Georgia, 30322, United States

Location

MeSH Terms

Conditions

Diabetes MellitusDiabetes Mellitus, Type 2

Interventions

Mindfulness-Based Stress ReductionMethods

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

MindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesInvestigative Techniques

Results Point of Contact

Title
Dayna Johnson, PhD, MPH, MSW, MS
Organization
Emory University

Study Officials

  • Dayna Johnson, PhD

    Emory University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

November 8, 2019

First Posted

November 12, 2019

Study Start

December 18, 2019

Primary Completion

August 17, 2021

Study Completion

August 29, 2021

Last Updated

September 28, 2022

Results First Posted

September 28, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will share

Statistical analysis plan will be available upon request. Data will be available one year after the first person is enrolled with no end date.

Shared Documents
SAP
Time Frame
One year after the first person is enrolled. No end date.
Access Criteria
Researchers upon request will be able to access data, for any purpose. Data will be shared via secure data transfer.

Locations